Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions

American Journal of Cardiology

Volumn 98, Issue 4, 2006, Pages 443-446

  Costa, Ricardo A ^a   Lansky, Alexandra J ^a   Abizaid, Alexandre ^b   Müeller, Ralph ^c   Tsuchiya, Yoshihiro ^a   Mori, Ken ^a   Cristea, Ecaterina ^a   Leon, Martin B ^a   Sousa, J Eduardo ^b   Schmidt, Thomas ^c   Hauptmann, Karl E ^d   Grube, Eberhard ^c  

^a NewYork Presbyterian Hospital   (United States)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c Heart Center Siegburg   (Germany)

^d Diabetes Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLIMUS A9; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DISEASE COURSE; ELUTION; EXPERIENCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT OUTCOME;

BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33746859774     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.02.051     Document Type: Article

References (7)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. Grube E., Sonoda S., Ikeno F., Honda Y., Kar S., Chan C., Gerckens U., Lansky A.J., and Fitzgerald P.J. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 109 (2004) 2168-2171
4. Costa R.A., Lansky A.J., Mintz G.S., Mehran R., Tsuchiya Y., Negoita M., Gilutz Y., Nikolsky E., Fahy M., Pop R., et al. Angiographic results of the first human experience with the everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). Am J Cardiol 95 (2005) 113-116
5. Grube E., Hauptmann K.E., Buellesfeld L., Lim V., and Abizaid A. Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9™{combining enclosing circle} eluting stent with a biodegradable polymer coating. Eurointervention 1 (2005) 53-57
6. Kar S., Aragon J., Tio F., Betts R., Shulze J., Reiver S., Savage D., Grant G., Kimchi E., Eigler N., and Litvack F. Biolimus A9. a new rapamycin derivative developed for stent applications inhibits intimal proliferation in a porcine model. Am J Cardiol 94 suppl 6A (2004) 151E
7. Sousa J.E., Costa M.A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M.F., Seixas A.C., Staico R., Mattos L.A., Sousa A.G.M.R., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries. a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195